Brawn Biotech Ltd — Important, 30-05-2026: Company Update

Brawn Biotech has confirmed it is not required to make certain related party transaction disclosures. As of March 31, 2026, the company's paid-up share capital was 3 Cr and net worth was approximately 4.32 Cr. These figures are below the specified thresholds of 10 Cr and 25 Cr, respectively, a condition met consistently for the past three financial years. This means the company is exempt from filing related party transactions for the half-year ended March 2026, streamlining its compliance processes.